Literature DB >> 23962537

WITHDRAWN: Immunogenicity and safety of HCV E1E2 peptide vaccine in chronically HCV-infected patients who did not respond to interferon based therapy.

Mostafa K El-Awady1, Mohamed El Gendy2, Imam Waked2, Ashraf A Tabll3, Yasmin El Abd3, Noha Bader El Din3, Reem El Shenawy3, Aleef Allam2, Tawfeek H Abdelhafez3, Reham M Dawood3.   

Abstract

This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2013        PMID: 23962537     DOI: 10.1016/j.vaccine.2013.07.074

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  2 in total

Review 1.  T cell responses to viral infections - opportunities for Peptide vaccination.

Authors:  Sietske Rosendahl Huber; Josine van Beek; Jørgen de Jonge; Willem Luytjes; Debbie van Baarle
Journal:  Front Immunol       Date:  2014-04-16       Impact factor: 7.561

2.  Recombinant tandem multi-linear neutralizing epitopes of human enterovirus 71 elicited protective immunity in mice.

Authors:  Yue-Xiang Li; Hui Zhao; Rui-Yuan Cao; Yong-Qiang Deng; Jian-Feng Han; Shun-Ya Zhu; Jie Ma; Long Liu; E-De Qin; Cheng-Feng Qin
Journal:  Virol J       Date:  2014-05-06       Impact factor: 4.099

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.